Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / ADR
-
Number of holders
-
796
-
Total 13F shares, excl. options
-
311,501,203
-
Shares change
-
+24,973,913
-
Total reported value, excl. options
-
$11,808,717,369
-
Value change
-
+$916,179,519
-
Put/Call ratio
-
58%
-
Number of buys
-
323
-
Number of sells
-
446
-
Price
-
$37.89
Institutional Holders of GLAXOSMITHKLINE PLC - ADR (GSK) as of Q1 2020
As of 31 Mar 2020 GLAXOSMITHKLINE PLC - ADR (GSK) had 796 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 311,501,203 shares of stock of the company.
Largest 10 holders included Dodge & Cox, RENAISSANCE TECHNOLOGIES LLC, FMR LLC, ROYAL BANK OF CANADA, PRICE T ROWE ASSOCIATES INC /MD/, Fisher Asset Management, LLC, Capital International Investors, Boston Partners, STATE STREET CORP, and HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC.
This table shows 804 institutional shareholders of the security as of 31 Mar 2020.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.